HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status,...

Roche Diagnostics is at the forefront of diagnostic certainty, empowering oncology decision-making with our VENTANA portfolio. We help our customers improve and grow by offering a wide range of high-quality medical tests and digital...

Rudy Hovelinck joins Pathomation as Chief Operational Officer (COO) on February 21, 2022. ANTWERP, BELGIUM (PRWEB) FEBRUARY 18, 2022 Pathomation today announced that Rudy Hovelinck will fill in the new position of Chief Operational Officer...

Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1,2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the...